Literature DB >> 6340999

Protective immunity to malaria and anti-erythrocyte autoimmunity.

W Jarra.   

Abstract

The intraerythrocytic development of malaria parasites results in considerable modification and destruction of erythrocytes. This may lead to the breaking of tolerance such that immune recognition of 'self' or 'modified self' erythrocyte antigens by B or T lymphocytes occurs. Such recognition may be a vital factor in the induction of protective immunity even though it may also cause immunopathology. Serological and immunocytochemical assays have been used to demonstrate, in the serum of Plasmodium berghei-infected or immune rats, antibodies to isoantigenic determinants on infected erythrocytes. Absorption studies indicated that antigens specifically associated with parasitized erythrocytes and erythrocyte isoantigens were closely associated at the surface membrane. Extensive erythrocyte modification and destruction, artificially generated by phenylhydrazine treatment, significantly enhanced immunity against rodent malaria. In contrast, the generation of an incomplete anti-erythrocyte autoantibody response in mice by the injection of cross-reacting rat erythrocytes failed to augment protective responses to P. chabaudi. The reinjection of rat erythrocytes into mice previously injected with rat erythrocytes suppresses further autoantibody synthesis and the mice revert to the normal (Coombs-negative) state. Spleen cells from rat erythrocyte-treated mice transfer this suppression when injected into syngeneic recipients. Coombs-negative mice reinjected with rat erythrocytes failed to show enhanced protective responses to P. chabaudi. Spleen cells from such Coombs-negative mice, injected into sublethally irradiated recipients, increased the protective effects of concurrently transferred spleen cells from malaria-immune donors when the recipients were challenged with P. chabaudi.

Entities:  

Mesh:

Year:  1983        PMID: 6340999     DOI: 10.1002/9780470715444.ch9

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  6 in total

1.  Sequential Plasmodium chabaudi and Plasmodium berghei infections provide a novel model of severe malarial anemia.

Authors:  Juliana V Harris; Tiffany M Bohr; Catherine Stracener; Mary E Landmesser; Vladimir Torres; Amos Mbugua; Chantal Moratz; José A Stoute
Journal:  Infect Immun       Date:  2012-06-11       Impact factor: 3.441

2.  Testosterone persistently dysregulates hepatic expression of Tlr6 and Tlr8 induced by Plasmodium chabaudi malaria.

Authors:  Saleh Al-Quraishy; Mohamed A Dkhil; Abdel-Azeem S Abdel-Baki; Marcos J Araúzo-Bravo; Denis Delic; Frank Wunderlich
Journal:  Parasitol Res       Date:  2014-07-24       Impact factor: 2.289

3.  Blood-stage malaria of Plasmodium chabaudi induces differential Tlr expression in the liver of susceptible and vaccination-protected Balb/c mice.

Authors:  Saleh Al-Quraishy; Mohamed A Dkhil; Suliman Alomar; Abdel Azeem S Abdel-Baki; Denis Delic; Frank Wunderlich; Marcos J Araúzo-Bravo
Journal:  Parasitol Res       Date:  2016-01-25       Impact factor: 2.289

4.  Exacerbation of autoimmune neuro-inflammation in mice cured from blood-stage Plasmodium berghei infection.

Authors:  Rodolfo Thomé; André Luis Bombeiro; Luidy Kazuo Issayama; Catarina Rapôso; Stefanie Costa Pinto Lopes; Thiago Alves da Costa; Rosária Di Gangi; Isadora Tassinari Ferreira; Ana Leda Figueiredo Longhini; Alexandre Leite Rodrigues Oliveira; Maria Alice da Cruz Höfling; Fábio Trindade Maranhão Costa; Liana Verinaud
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

5.  Liver-inherent immune system: its role in blood-stage malaria.

Authors:  Frank Wunderlich; Saleh Al-Quraishy; Mohamed A Dkhil
Journal:  Front Microbiol       Date:  2014-11-04       Impact factor: 5.640

6.  Plasmodium DNA-mediated TLR9 activation of T-bet+ B cells contributes to autoimmune anaemia during malaria.

Authors:  J Rivera-Correa; J J Guthmiller; R Vijay; C Fernandez-Arias; M A Pardo-Ruge; S Gonzalez; N S Butler; A Rodriguez
Journal:  Nat Commun       Date:  2017-11-03       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.